WebMD

FDA Approves Rhapsido for People With Hives Triggered by Skin Rubbing

The FDA has approved Rhapsido (remibrutinib) for adults with symptomatic dermographism who remain symptomatic despite use of ...
WebMD

FDA Approves Tukysa Maintenance Treatment for HER2-Positive Metastatic Breast Cancer

The FDA has approved Tukysa (tucatinib) combined with trastuzumab and pertuzumab for the maintenance treatment of adult ...
WebMD

FDA Approves Jaypirca for First-Time Treatment of Certain Blood Cancers

The FDA has approved Jaypirca (pirtobrutinib) for adults with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma without a 17p deletion.
WebMD

FDA Approves Atebrioz to Reduce Extra Bone Growth in Rare Gene Disorder

The FDA has approved Atebrioz (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification in adults and pediatric patients aged 12 years or older with fibrodysplasia ossificans ...